InfoMedSearch Newsletters
Coronary Artery Disease (CAD)

:: November 2009


Welcome to our Monthly Online Newsletter!


View all Treatment articles in our Treatment Report . The most recent articles are listed on top (not in alphabetical order). Click on the Topic on our home page and then the subtopic - Treatment Report. Stay updated on drugs and their side effects, and various other treatments, including exercise, nutrition, and supplements.

Highlighted Article

Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Disease Protection “The current AHA guidelines recommended combined EPA and DHA in a dose of approximately 1000 mg/day in patients with CHD.17 This dose may also now be appropriate for patients with HF.1,12,14 Since few patients eat four or more oily fish meals per week, this dosage of EPA + DHA would generally require two or three OTC fish oil capsules, depending on the exact concentrations of EPA and DHA (equivalent to one Lovaza, which is not FDA-approved for this indication). In patients with elevated triglycerides, 3-5 g/day of EPA + DHA would be needed, which generally would require between 6-12 OTC fish oil capsules (or 4 Lovaza, the FDA-approved preparation). Conclusions Based on considerable evidence, the target EPA + DHA consumption should be at least 500 mg/day for individuals without overt CV diseases, and at least 800-1000 mg/day for individuals with known CHD and HF. As was recently reviewed in detail, 1 further studies are needed to determine optimal dosing and the relative ratio of DHA and EPA that provides maximal CV protection in those at risk of CV diseases, as well as in the treatment of atherosclerosis, arrhythmias, and primary myocardial disorders. However, the constellation of data suggests that this story represents a "fish tale with growing credibility."1 “

Clinical Guidelines

ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention

ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention

NGC - Acute coronary syndromes: 2005 International Consensus Conference on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. (2005)

NGC - ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease). (2006)

NGC - Acute coronary syndromes. A national clinical guideline. (2006)

NGC - Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. (2004)

NGC - Cardiac arrhythmias in coronary heart disease. A national clinical guideline. (2007)

NGC - Chronic chest pain—suspected cardiac origin. (2006)

NGC - Coronary angiography and indications for CABG or angioplasty. (2004)

NGC - Coronary heart disease (CHD): symptoms, diagnosis and treatment. (2008)

NGC - Diagnosis and treatment of chest pain and acute coronary syndrome (ACS). (2006)

NGC - Differential diagnosis of chest pain. (2008)

NGC - Evaluation of primary care patients with chronic stable angina: guidelines from the American College of Physicians. (2004)

NGC - Gender-specific practice guidelines for coronary artery bypass surgery. (2004)

NGC - Practice advisory for the perioperative management of patients with cardiac rhythm management devices: pacemakers and implantable cardioverter-defibrillators: a report by the American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Cardiac Rhythm Management Devices. (2005)

NGC - Primary care management of chronic stable angina and asymptomatic suspected or known coronary artery disease: a clinical practice guideline from the American College of Physicians. (2004)

NGC - Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease. (2005)

NGC - Secondary prevention of coronary artery disease clinical practice guidelines. (2006)

NGC - Shortness of breath--suspected cardiac origin. (2006)

NGC - Stable coronary artery disease. (2006)

NGC - The Society of Thoracic Surgeons practice guideline series: aspirin and other anti-platelet agents during operative coronary revascularization. (2003)

NGC - Unstable angina pectoris. (2006)

NGC - VA/DoD clinical practice guideline for management of ischemic heart disease.

SIGN - Acute coronary syndromes (2007)

SIGN - Cardiac arrhythmias in coronary heart disease (2007)

Internet Sites

Related InfoMedSearch Topics (2 selected)

Related Topics - Highlighted Articles

Diet - Health


Fitness - Exercise

 

Diagnosis, Imaging, and Screening

 

General Information
Risk Factors

Size Matters -- Obesity Leading Risk Factor for Heart Condition “In individuals with high blood pressure, the heart has to deal with greater pressure, which results in a thickening of the walls of the left ventricle. This change also affects the left atrium as the pressure in this chamber ultimately increases as well as resulting in enlargement and loss of function of the atrium. The mechanisms by which obesity might promote the increased size of the left atrium are seemingly more complex. Obese subjects may undergo dilatation of this chamber because of the cardiac output. The heart of an obese person must transport more blood per minute, which may lead to a volume overload in the left atrium.”

 

Risk Reduction

 

© 2004-2008 InfoMedSearch, LLC. All Rights Reserved. | Design: mqstudio | Disclaimer